The revolutionary impact of immune checkpoint inhibitors (ICIs) has transformed cancer care, yielding unprecedented durable responses across a spectru
Read Full Article To Earn PointsDaily news to keep you up to date
Participate and win exciting prizes
Participate and win cash vouchers
Get updates on the latest events happening around the world
1.
NIH research cuts leave cancer patient facing hard choice
2.
Study confirms safety and efficacy of higher-dose-per-day radiation for early-stage prostate cancer
3.
AI Model as Effective as Radiologists in Detecting Prostate Cancer on MRI
4.
Tumor-targeting fluorescent bacteria illuminate cancer for precision surgery
5.
New surgical method shows promising results for cervical cancer treatment
1.
First-Line Immuno-Hematology Examinations: Essential Diagnostic Tools for Patient Care
2.
Chemotherapy Advances: Albumin I.V., Trastuzumab, Liposomal Doxorubicin & More
3.
Different Types of Blood Dyscrasias
4.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
5.
How to Prevent Tumor Lysis Syndrome in Cancer Patients
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
2.
An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII
4.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation